Semaglutide Samples: Compounded & Brand-Name Programs (2026)
Semaglutide is the GLP-1 agonist active ingredient in three FDA-approved brand-name products — Ozempic (Type 2 diabetes), Wegovy (weight management), and Rybelsus (oral tablet, diabetes) — plus a large and still-active compounded market prepared at licensed 503A and 503B pharmacies.
For patients who search "semaglutide samples" rather than a specific brand, the question usually comes down to compounded versus brand-name. Compounded semaglutide is cheaper, prescribed off-label, and not FDA-reviewed as a specific preparation. Brand-name semaglutide is more expensive, FDA-reviewed, and backed by manufacturer savings programs for eligible patients.
This guide maps the full 2026 semaglutide landscape — when compounded is the right call, which brand-name path produces the lowest real cost for each patient profile, and what has changed in the compounded market after the FDA's 2025 re-classification work.
What's actually available: Semaglutide samples in 2026
Three paths for people typing “semaglutidesamples” — what they actually mean, typical cost, and who each path fits.
| Path | What it actually is | Typical cost | Best for |
|---|---|---|---|
| Compounded semaglutide | 503A/503B pharmacy preparation against individual prescription; not FDA-reviewed as a product. | $179–$349 / month all-in | Cash-pay patients comfortable with compounded preparations |
| Brand-name Wegovy (NovoCare) | Novo Nordisk's direct cash pharmacy for brand-name Wegovy. | $499 / 28-day supply | Cash-pay patients who want brand Wegovy for weight loss |
| Brand Ozempic or Rybelsus (savings card) | Manufacturer copay assistance for commercially insured diabetes patients. | $10–$25 / month (insured) | Diabetes patients with commercial plan coverage |
How Semaglutide sample programs actually work
Compounded semaglutide after the 2025 shortage delisting
FDA removed semaglutide from the Drug Shortage List in February 2025. 503A compounding pharmacies — which can compound against individual prescriptions under personalization rules — had to substantially narrow their semaglutide production to specific clinical scenarios (documented allergy to a Wegovy excipient, need for a non-commercial dose). 503B outsourcing facilities operate under different rules and continue meaningful semaglutide production. The practical result: fewer large-scale compounded semaglutide programs than in 2024, but the reputable ones that remain are well-established.
How to verify a compounded semaglutide pharmacy
Every legitimate compounding pharmacy has a verifiable state board of pharmacy license. 503B outsourcing facilities are additionally registered with the FDA. The compounding telehealth programs we recommend disclose their pharmacy partner and license number on their site or in response to a direct question. Any program that won't name its pharmacy partner is a red flag.
When brand-name semaglutide beats compounded on cost
Most patients assume compounded is always cheaper. It usually is, but not always. Commercially insured diabetes patients with plan coverage pay $10–$25/month on Rybelsus, Ozempic, or Wegovy through manufacturer savings cards — below most compounded prices. For this specific cohort, the brand-name path wins on cost and wins on regulatory clarity.
Which telehealth providers specialize in semaglutide
Henry Meds, Mochi Health, and LifeMD are the largest compounded-semaglutide-focused telehealth programs. Ro, Found, WeightWatchers Clinic, and Hims all run both brand-name and compounded semaglutide workflows. The distinguishing factor between good and bad providers is typically the quality of the clinician intake — programs that prescribe without meaningful clinical review are the ones we deprioritize in our rankings.
The semaglutide market is the most price-spread category in modern medicine — the same molecule sells for $10 or $1,349 depending on which door you walk through.
Top providers offering Semaglutide or the compounded alternative
Providers we've verified currently support a clinically appropriate Semaglutide path. Pricing and availability vary by state. Every link is an affiliate link tracked through Impact Engine — see our disclosure.
| Rank | Provider | Best for | Sample type | Editor | Readers | Action |
|---|---|---|---|---|---|---|
| #1 | Henry Meds Compounded Semaglutide · Compounded Tirzepatide | best-for-compounded | telehealth | 4.6 / 5 | — | See offer |
| #2 | Mochi Health Compounded Semaglutide · Compounded Tirzepatide | best-for-clinical-support | telehealth | 4.4 / 5 | — | See offer |
| #3 | Ro Body Semaglutide · Tirzepatide | best-for-branded-rx | telehealth | 4.3 / 5 | — | See offer |
| #4 | Sesame Care Semaglutide · Tirzepatide | best-for-one-time-visit | telehealth | 4.2 / 5 | — | See offer |
| #5 | Hims Weight Loss Compounded Semaglutide · Liraglutide | best-for-brand-name | telehealth | 4.1 / 5 | — | See offer |
| #6 | Found Semaglutide · Tirzepatide | best-for-insurance-coverage | telehealth | 4.0 / 5 | — | See offer |
| #7 | LifeMD Semaglutide · Tirzepatide | best-for-regulated-provider | telehealth | 4.0 / 5 | — | See offer |
| #8 | WeightWatchers Clinic Semaglutide · Tirzepatide | best-for-lifestyle-bundle | telehealth | 3.9 / 5 | — | See offer |
Henry Meds
Flat-rate compounded GLP-1 with a free telehealth consult to see if you qualify.
- ✓ Free intake consult
- ✓ Flat monthly price, no insurance needed
- ✓ No long-term contract
- − Not available in all states
- − Supply constraints during GLP-1 shortages
- − Compounded only (no branded Ozempic/Wegovy)
Mochi Health
Compounded GLP-1 with a dietitian-led program and insurance-billing option.
- ✓ Includes dietitian visits
- ✓ Insurance billing available
- ✓ Strong clinical team
- − Higher price than cash-only peers
- − Intake can take several days
- − US only
Ro Body
Major branded-Rx telehealth with a dedicated GLP-1 weight-loss program.
- ✓ Branded Wegovy / Zepbound when available
- ✓ Insurance coordination support
- ✓ Established national brand
- − Higher monthly cost
- − Intake and shipping slower than lean competitors
- − Not all medications in stock in all states
Sesame Care
A la carte telehealth where you pay per visit and get real GLP-1 prescriptions at list pricing.
- ✓ No subscription or recurring fee
- ✓ Pay once for the consult
- ✓ Use your own pharmacy + GoodRx
- − Medication cost is separate
- − No built-in coaching or support
- − Availability varies by state
Hims Weight Loss
National telehealth brand with an oral-and-injectable weight-loss lineup.
- ✓ Bundled flat pricing
- ✓ Major national brand
- ✓ Both oral and injectable options
- − Clinical customization limited vs. peers
- − Compounded only (no branded Rx)
- − Higher churn on 12-month subscriptions
Semaglutide cost in 2026: every legitimate price path
What you'll actually pay depends on insurance, the path you take, and whether you stay on the brand-name drug. Here's the real money:
| Path | First month | Ongoing | Notes |
|---|---|---|---|
| Compounded semaglutide (reputable) | $149–$249 (promo) | $249–$349/mo | Telehealth-bundled; pharmacy disclosed; state-licensed. |
| Brand Wegovy (NovoCare cash) | $499 | $499/mo | Direct-to-patient cash channel for uninsured. |
| Brand Wegovy (savings card, covered plan) | $0–$25 | $0–$25/mo | Commercial insurance + approved PA required. |
| Brand Ozempic (savings card, covered plan) | $25 | $25/mo | Type 2 diabetes indication required for clean coverage. |
| Brand Rybelsus (savings card, covered plan) | $10 | $10/mo | Oral tablet; diabetes indication; strict dosing rules. |
| Retail brand cash (any) | $998–$1,349 | Same | No insurance or manufacturer assistance. |
What to expect on Semaglutide: your first weeks
Semaglutide titration is slow and deliberate regardless of brand. Injectables start at 0.25 mg weekly and step up monthly. Oral Rybelsus starts at 3 mg daily. Most patients take 4–5 months to reach their maintenance dose.
Clinical response differs by indication. For diabetes, A1C response at 12 weeks. For weight management, appetite change in weeks 2–4, visible weight change in weeks 8–12, and the full trial-magnitude response at 68 weeks.
GI side effects are the single most common reason patients discontinue — roughly 5–7% in trials. Good clinician support through the first 8 weeks is the difference between discontinuation and successful titration.
Clinical evidence behind Semaglutide
Semaglutide's clinical evidence base is the deepest in the GLP-1 class. SUSTAIN (Ozempic, 2016–2019), STEP (Wegovy, 2020–2022), PIONEER (Rybelsus, 2018–2020), and SELECT (cardiovascular outcomes, 2023) together enrolled tens of thousands of patients across dozens of trials. Mean A1C reduction at therapeutic doses is 1.1–1.8 percentage points; mean weight loss at the 2.4 mg obesity dose is 14.9% at 68 weeks. SELECT established a 20% relative reduction in major adverse cardiovascular events in patients with established cardiovascular disease and overweight/obesity.
Semaglutideside effects & who shouldn't take it
This is not medical advice. Discuss every medication decision with a licensed clinician who knows your full medical history.
Common side effects
- •Nausea (most common across all semaglutide products)
- •Constipation or diarrhea
- •Vomiting at dose escalation
- •Decreased appetite
- •Injection-site reactions (Ozempic, Wegovy)
- •Rare but serious: pancreatitis, gallbladder disease, MTC boxed warning
Who shouldn't take Semaglutide
- •Personal or family history of medullary thyroid carcinoma
- •Multiple endocrine neoplasia syndrome type 2
- •Pregnancy or planned pregnancy within 2 months
- •Severe pancreatitis history
- •Type 1 diabetes (semaglutide isn't approved for this indication)
Eligibility for Semaglutide
- •Varies by product: diabetes indication (Ozempic, Rybelsus) or weight-management indication (Wegovy)
- •BMI criteria for Wegovy: ≥30, or ≥27 with comorbidity
- •No contraindications (thyroid carcinoma history, MEN 2, severe pancreatitis)
- •Commercial insurance for savings card value; federal plans excluded
Semaglutide samples: frequently asked
Is compounded semaglutide the same as Ozempic or Wegovy?
Same active ingredient (semaglutide), different legal and regulatory category. Compounded semaglutide is prepared at a 503A or 503B pharmacy against an individual prescription; brand-name Ozempic and Wegovy are FDA-approved products with specific doses and delivery devices.
Is compounded semaglutide safe?
Reputable compounded semaglutide is prepared at state-licensed 503A or FDA-registered 503B pharmacies following USP compounding standards. Safety depends on the specific pharmacy's quality controls. Verify any pharmacy's licensure before use.
Are compounded semaglutide samples actually free?
Some compounded semaglutide programs offer promotional first-month pricing (e.g., $149 for first month, then $249–$349 ongoing). These are discounts, not free samples in the traditional manufacturer-distributed sense.
How much is compounded semaglutide per month?
Reputable 503A/503B programs run $179–$349 per month all-in, including the telehealth consult. Prices above $400/month for compounded semaglutide are usually inflated; prices below $150/month are usually a red flag for quality or regulatory corner-cutting.
Will insurance cover compounded semaglutide?
Almost never. Compounded preparations are not FDA-approved products and typically aren't on insurance formularies. Compounded semaglutide programs are built around cash-pay.
Can I switch from compounded to brand-name semaglutide?
Yes, with a new prescription. Clinicians typically transition at an equivalent titration step; most patients tolerate the switch without dose adjustment.
Does semaglutide require a prescription?
Yes, every form of semaglutide in the U.S. requires a prescription from a licensed clinician. This includes both brand-name products and compounded preparations.
Will compounded semaglutide still be available in 2026?
Yes, but the market has narrowed since FDA's 2025 shortage delisting. Reputable 503A/503B programs continue to operate; the unvetted fringe programs have largely exited the market under regulatory pressure.